[Asia Economy Reporter Lee Seon-ae]
▲SK Bioscience=Applied for IND of Phase 3 clinical trial in Nepal for heterologous booster shot of COVID-19 vaccine GBP510
▲CJ CheilJedang=Preliminarily estimated consolidated operating profit for Q2 this year at KRW 504.3 billion, up 7.4% from the same period last year
▲CJ Logistics=Preliminarily estimated consolidated operating profit for Q2 this year at KRW 116.1 billion, up 28.2% from the same period last year
▲Youngheung=Decided on a KRW 7 billion debt guarantee for subsidiary Daehotuksugang
▲Kia=Purchased other securities worth KRW 20 billion from Hyundai Motor Securities for stable fund management and profitability improvement
▲LX Hausys=Decided to increase short-term borrowings by KRW 50 billion for operating fund procurement
▲Inbiogen=Decided on a KRW 30 billion third-party allotment capital increase
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While All Eyes Were on Samsung and Hynix, This Company Surged 50% to New Highs in Four Days [Weekend Money]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
▲Korea Asset Trust=Decided to purchase commercial paper (CP) worth KRW 60 billion from affiliate Korea Asset Capital
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
